Abivax S.A. (ADR)
General ticker "ABVX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $6.4B (TTM average)
Abivax S.A. (ADR) follows the US Stock Market performance with the rate: 41.3%.
Estimated limits based on current volatility of 2.2%: low 95.31$, high 102.19$
Factors to consider:
- Total employees count: 1000 as of 2024
Short-term ABVX quotes
Long-term ABVX plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €0.00MM | €0.00MM | €0.00MM |
| Operating Expenses | €127.38MM | €172.98MM | €246.06MM |
| Operating Income | €-127.38MM | €-172.98MM | €-246.06MM |
| Non-Operating Income | €-20.36MM | €-3.26MM | €-84.20MM |
| Interest Expense | €13.83MM | €12.43MM | €28.48MM |
| R&D Expense | €103.18MM | €146.53MM | €177.76MM |
| Income(Loss) | €-147.74MM | €-176.24MM | €-330.25MM |
| Taxes | €0.00MM | €0.00MM | €5.85MM |
| Net Income(Loss)* | €-147.74MM | €-176.24MM | €-322.84MM |
| Stockholders Equity | €196.01MM | €40.58MM | €455.01MM |
| Assets | €327.06MM | €205.23MM | €584.09MM |
| Operating Cash Flow | €-100.01MM | €-154.07MM | €-155.69MM |
| Capital expenditure | €0.27MM | €0.64MM | €0.14MM |
| Investing Cash Flow | €-10.49MM | €15.76MM | €-13.18MM |
| Financing Cash Flow | €340.57MM | €28.21MM | €531.94MM |
| Earnings Per Share** | €-3.43 | €-2.80 | €-4.64 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.